GOVX
|GeoVax Labs Inc
NASDAQ
USD 1.07
+0.04|+3.37%
Current Price
USD 1.07
Change
+USD 0.04 (3.37%)
P/E Ratio
Dividend Yield
Market Cap
16.41M
Volume
88,936
Open
USD 1.03
Previous Close
USD 1.04
52-Week High
USD 11.18
52-Week Low
USD 0.73
About GeoVax Labs Inc
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tu...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. David Alan Dodd
Employees:17
Headquarters:Smyrna, USA
Website:www.geovax.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions